One report revealed that the combination of G-CSF, ATRA, and the low dose cytotoxic drug cytarabine ocfosfate (a prodrug of araC) led to complete remission (CR) in a 67-year old patient with AML (M2) [112]. Here, CSF3 is linked to acute myeloid leukemia.